Share
Share
Arbor Research Collaborative for Health (Arbor Research) recently welcomed Dr. Ping Yu, as Chief Growth Officer. In his new role at Arbor Research, Dr. Yu will lead the Strategic Growth Team (SGT) to further expand Arbor Research’s growth initiatives.
Dr. Yu brings a wealth of experience in health data, analytics, research, and evaluation, with a distinguished career spanning close to 40 years in the contract research arena. Previously creating and overseeing Booz Allen’s social science research practice as its Principal, Dr. Yu played a pivotal role in driving strategies to expand capabilities across health, especially in data science, analytics, research, and evaluation. Dr. Yu has designed and executed evaluations for healthcare quality improvement programs for the Centers for Medicare and Medicaid Services (CMS) and has developed innovative methodology and advanced analytics to help Federal Government agencies and other clients drive their mission and assess their programs’ return on investment. His leadership extends to multiyear, multimillion projects for clients such as CMS, Centers for Disease Control and Prevention, and Substance Abuse and Mental Health Services Administration (SAMHSA). Notably, he led the CMS Independence Evaluation Contract (IEC) and conducted significant studies for SAMHSA in the behavioral health domain.
Before his tenure at Booz Allen, Dr. Yu directed the Substance Abuse Research and Evaluation Group at Battelle Memorial Institute, where he also collaborated with the Chinese Academy of Sciences in the Joint Center for International Research. His diverse background includes work in support of the pharmaceutical industry with technical expertise in surveys, statistics and demography, business development, pricing, and project management.
Dr. Yu holds a Ph.D. in Demography from Cornell University, an M.A. from Georgetown University, and a B.A. in American Studies from Canton University of Trade and Foreign Languages.
Expressing his enthusiasm, Dr. Yu stated, “I am excited to contribute to the growth and success of Arbor Research. Returning to a small business environment feels like coming full circle in my career. I look forward to collaborating with every staff at every level and achieving Arbor’s ambitious 5-year strategic plan.”
“Dr. Yu’s extensive experience and strategic vision will play a pivotal role in advancing Arbor’s mission and fostering our continued success in the research and evaluation sector,” says President and CEO of Arbor Research, Dr. Christopher Spera. “Ping’s charge will continue the strong success of the SGT and continue to build out the growth function within Arbor.”
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level […]
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) […]